# Cutaneous Melanoma Detection and Management

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the diagnosis, treatment, and epidemiology of melanoma, a type of skin cancer. It covers topics such as dermatologist-level classification, genetic alterations, sentinel lymph node biopsy, immunotherapy, tumor staging, deep learning for melanoma recognition, and survival analysis. The papers also discuss the epidemiological trends and risk factors associated with melanoma. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10392 |
| Works | 248 |

## Topic papers all

Showing 15 of 248.

- [Final Version of 2009 AJCC Melanoma Staging and Classification](https://scholariq.org/papers/final-version-of-2009-ajcc-melanoma-staging-and-classification/)
- [Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma](https://scholariq.org/papers/ipilimumab-plus-dacarbazine-for-previously-untreated-metastatic-melanoma/)
- [Genomic Classification of Cutaneous Melanoma](https://scholariq.org/papers/genomic-classification-of-cutaneous-melanoma/)
- [Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma](https://scholariq.org/papers/final-version-of-the-american-joint-committee-on-cancer-staging-system-for/)
- [Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System](https://scholariq.org/papers/prognostic-factors-analysis-of-17-600-melanoma-patients-validation-of-the/)
- [Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.](https://scholariq.org/papers/interferon-alfa-2b-adjuvant-therapy-of-high-risk-resected-cutaneous-melanoma-the/)
- [Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma](https://scholariq.org/papers/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma/)
- [Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe](https://scholariq.org/papers/surgical-resection-and-radiolocalization-of-the-sentinel-lymph-node-in-breast/)
- [Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma](https://scholariq.org/papers/completion-dissection-or-observation-for-sentinel-node-metastasis-in-melanoma/)
- [Dermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet](https://scholariq.org/papers/dermoscopy-of-pigmented-skin-lesions-results-of-a-consensus-meeting-via-the/)
- [Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial](https://scholariq.org/papers/dose-dense-temozolomide-for-newly-diagnosed-glioblastoma-a-randomized-phase-iii/)
- [EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of <i>BRAF</i> -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib](https://scholariq.org/papers/egfr-mediated-reactivation-of-mapk-signaling-contributes-to-insensitivity-of-i/)
- [Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study](https://scholariq.org/papers/combination-nivolumab-and-ipilimumab-or-nivolumab-alone-in-melanoma-brain/)
- [Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study](https://scholariq.org/papers/epacadostat-plus-pembrolizumab-versus-placebo-plus-pembrolizumab-in-patients/)
- [Human–computer collaboration for skin cancer recognition](https://scholariq.org/papers/human-computer-collaboration-for-skin-cancer-recognition/)

## Topic primary papers

Showing 15 of 139.

- [Final Version of 2009 AJCC Melanoma Staging and Classification](https://scholariq.org/papers/final-version-of-2009-ajcc-melanoma-staging-and-classification/)
- [Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma](https://scholariq.org/papers/final-version-of-the-american-joint-committee-on-cancer-staging-system-for/)
- [Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System](https://scholariq.org/papers/prognostic-factors-analysis-of-17-600-melanoma-patients-validation-of-the/)
- [Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.](https://scholariq.org/papers/interferon-alfa-2b-adjuvant-therapy-of-high-risk-resected-cutaneous-melanoma-the/)
- [Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe](https://scholariq.org/papers/surgical-resection-and-radiolocalization-of-the-sentinel-lymph-node-in-breast/)
- [Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma](https://scholariq.org/papers/completion-dissection-or-observation-for-sentinel-node-metastasis-in-melanoma/)
- [Dermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet](https://scholariq.org/papers/dermoscopy-of-pigmented-skin-lesions-results-of-a-consensus-meeting-via-the/)
- [Human–computer collaboration for skin cancer recognition](https://scholariq.org/papers/human-computer-collaboration-for-skin-cancer-recognition/)
- [High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190](https://scholariq.org/papers/high-and-low-dose-interferon-alfa-2b-in-high-risk-melanoma-first-analysis-of/)
- [Epiluminescence Microscopy for the Diagnosis of Doubtful Melanocytic Skin Lesions](https://scholariq.org/papers/epiluminescence-microscopy-for-the-diagnosis-of-doubtful-melanocytic-skin/)
- [Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma](https://scholariq.org/papers/neoadjuvant-adjuvant-or-adjuvant-only-pembrolizumab-in-advanced-melanoma/)
- [Increasing Burden of Melanoma in the United States](https://scholariq.org/papers/increasing-burden-of-melanoma-in-the-united-states/)
- [Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma](https://scholariq.org/papers/validation-of-the-accuracy-of-intraoperative-lymphatic-mapping-and-sentinel/)
- [Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016](https://scholariq.org/papers/diagnosis-and-treatment-of-melanoma-european-consensus-based-interdisciplinary/)
- [Seven-Point Checklist and Skin Lesion Classification Using Multitask Multimodal Neural Nets](https://scholariq.org/papers/seven-point-checklist-and-skin-lesion-classification-using-multitask-multimodal/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.